A Study of the Impact of an Early Biopsy in Patients Treated With CellCept (Mycophenolate Mofetil) After Kidney Transplantation

NCT00817687 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplantation

Interventions

DRUG: mycophenolate mofetil [CellCept]
DRUG: mycophenolate mofetil [CellCept]

Sponsor

Hoffmann-La Roche